Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 19:10:53 UTC |
---|
Update Date | 2021-09-26 23:14:40 UTC |
---|
HMDB ID | HMDB0258011 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid |
---|
Description | fluoro({[3-hydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Based on a literature review very few articles have been published on fluoro({[3-hydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). [(2r,3s,5r)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC1CC(OC1COP(O)(F)=O)N1C=CC(=O)NC1=O InChI=1S/C9H12FN2O7P/c10-20(16,17)18-4-6-5(13)3-8(19-6)12-2-1-7(14)11-9(12)15/h1-2,5-6,8,13H,3-4H2,(H,16,17)(H,11,14,15) |
---|
Synonyms | Value | Source |
---|
Fluoro({[3-hydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinate | Generator | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinate | Generator |
|
---|
Chemical Formula | C9H12FN2O7P |
---|
Average Molecular Weight | 310.174 |
---|
Monoisotopic Molecular Weight | 310.036615895 |
---|
IUPAC Name | {[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphinoyl fluoride |
---|
Traditional Name | [5-(2,4-dioxo-3H-pyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy(hydroxy)phosphinoyl fluoride |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC1CC(OC1COP(O)(F)=O)N1C=CC(=O)NC1=O |
---|
InChI Identifier | InChI=1S/C9H12FN2O7P/c10-20(16,17)18-4-6-5(13)3-8(19-6)12-2-1-7(14)11-9(12)15/h1-2,5-6,8,13H,3-4H2,(H,16,17)(H,11,14,15) |
---|
InChI Key | QYAKHWNNJJLYOP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrimidine nucleosides |
---|
Sub Class | Pyrimidine 2'-deoxyribonucleosides |
---|
Direct Parent | Pyrimidine 2'-deoxyribonucleosides |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidine 2'-deoxyribonucleoside
- Hydroxypyrimidine
- Pyrimidone
- Hydropyrimidine
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Pyrimidine
- Oxolane
- Heteroaromatic compound
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 154.752 | 30932474 | DeepCCS | [M-H]- | 152.394 | 30932474 | DeepCCS | [M-2H]- | 185.279 | 30932474 | DeepCCS | [M+Na]+ | 160.846 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
[(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 2570.7 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 2600.5 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 3045.5 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #2 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(O)F | 2556.2 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #2 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(O)F | 2671.9 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #2 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(O)F | 3298.4 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #3 | C[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C)C2=O)CC1O | 2602.6 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #3 | C[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C)C2=O)CC1O | 2683.2 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TMS,isomer #3 | C[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C)C2=O)CC1O | 3170.5 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 2608.1 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 2703.7 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TMS,isomer #1 | C[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C | 2819.5 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3006.0 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3046.0 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)[NH]C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3232.2 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(O)F | 3011.0 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(O)F | 3101.0 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(O)F | 3378.5 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)CC1O | 3035.0 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)CC1O | 3096.5 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OP(=O)(F)OCC1OC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)CC1O | 3274.1 | Standard polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3265.8 | Semi standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3303.6 | Standard non polar | 33892256 | [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(N2C=CC(=O)N([Si](C)(C)C(C)(C)C)C2=O)OC1COP(=O)(F)O[Si](C)(C)C(C)(C)C | 3052.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-01ow-9510000000-eafa48b5464bc05f3fe9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - [(2R,3S,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-fluorophosphinic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
---|